| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3297401 | Gastroenterology | 2011 | 11 Pages |
Abstract
A high proportion (>80%) of patients achieved an SVR regardless of the telaprevir dosing frequency (q8h or q12h) or type of peginterferon alfa used (alfa-2a or alfa-2b).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Patrick Marcellin, Xavier Forns, Tobias Goeser, Peter Ferenci, Frederik Nevens, Giampiero Carosi, Joost P. Drenth, Lawrence Serfaty, Koen De Backer, Rolf Van Heeswijk, Donghan Luo, Gaston Picchio, Maria Beumont,